Cardiovascular effects of milrinone.

Cardiovascular effects of milrinone.

Item
http://www.wikidata.org/entity/Q37721684
Phosphodiesterase III inhibitors for heart failureAnti-platelet therapy: phosphodiesterase inhibitors.Safety and efficacy of the off-label use of milrinone in pediatric patients with heart diseasesAcute circulatory support.Use of inotropes and vasopressor agents in critically ill patients.Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heartTargeting phosphodiesterases in anti-platelet therapyCardiac Myosin Activators in Systolic Heart Failure: More Friend than Foe?Phosphodiesterase-III Inhibitors Amrinone and Milrinone on Epilepsy and Cardiovascular Activities.Genetic Understanding of Stroke Treatment: Potential Role for Phosphodiesterase Inhibitors.Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
P2860

Cardiovascular effects of milrinone.

Item
http://www.wikidata.org/entity/Q37721684
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular effects of milrinone.
@en
Cardiovascular effects of milrinone.
@nl
type
label
Cardiovascular effects of milrinone.
@en
Cardiovascular effects of milrinone.
@nl
prefLabel
Cardiovascular effects of milrinone.
@en
Cardiovascular effects of milrinone.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Cardiovascular effects of milrinone.
@en
P2093
P304
P31
P356
10.1016/0002-8703(91)90829-7
P407
P433
P478
P577
P698
P921